Related Experiment Video
Updated: May 17, 2026

Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry
Published on: March 28, 2014
Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions
Beatriz Pelaz1, Gaëlle Charron, Christian Pfeiffer
1Instituto de Nanociencia de Aragon (INA), Universidad de Zaragoza, 50018 Zaragoza, Spain.
Engineered nanomaterials offer advanced medical applications in therapy and diagnosis. However, understanding their interactions with biological systems and potential adverse effects is crucial for safe and effective use.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Toxicology
Background:
- Engineered nanomaterials are increasingly utilized in medicine for diagnosis and therapy.
- Advances in synthesis allow for complex nanomaterials with diverse biological functions.
- Applications span sensing, imaging, drug delivery, and more.
Purpose of the Study:
- To review recent progress on nanomaterial interactions with biological systems.
- To highlight emerging challenges and areas of importance in nanotoxicology.
- To discuss adverse effects associated with nanomaterial use in a biological context.
Main Methods:
- Literature review of recent advancements in nanomaterial applications and interactions.
- Analysis of reported beneficial and adverse effects of nanomaterials in biological systems.
- Discussion of the relationship between physicochemical properties and biological outcomes.
Main Results:
- Engineered nanomaterials show great promise for enhanced medical applications.
- Interfacing nanomaterials with biological systems can trigger adverse effects like toxicity and aggregation.
- Standardized protocols for assessing nanomaterial safety and bio-performance are still developing.
Conclusions:
- Continued research into nanomaterial-biology interactions is essential.
- Nanotoxicology is a critical emerging field for evaluating safety and efficacy.
- Careful analysis of potential adverse effects is necessary for responsible innovation in nanomedicine.
More Related Videos
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022